YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit

被引:150
作者
Cemal, CK
Carroll, CJ
Lawrence, L
Lowrie, MB
Ruddle, P
Al-Mahdawi, S
King, RHM
Pook, MA
Huxley, C
Chamberlain, S
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England
[2] UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England
关键词
D O I
10.1093/hmg/11.9.1075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Machado-Joseph disease (MJD; MIM 109150) is a late-onset neurodegenerative disorder caused by the expansion of a polyglutamine tract within the MJD1 gene. We have previously reported the generation of human yeast artificial chromosome (YAC) constructs encompassing the MJD1 locus into which expanded (CAG)(76) and (CAG)(84) repeat motifs have been introduced by homologous recombination. Transgenic mice containing pathological alleles with polyglutamine tract lengths of 64, 67, 72, 76 and 84 repeats, as well as the wild type with 15 repeats, have now been generated using these YAC constructs. The mice with expanded alleles demonstrate a mild and slowly progressive cerebellar deficit, manifesting as early as 4 weeks of age. As the disease progresses, pelvic elevation becomes markedly flattened, accompanied by hypotonia, and motor and sensory loss. Neuronal intranuclear inclusion (NII) formation and cell loss is prominent in the pontine and dentate nuclei, with variable cell loss in other regions of the cerebellum from 4 weeks of age. Interestingly, peripheral nerve demyelination and axonal loss is detected in symptomatic mice from 26 weeks of age. In contrast, transgenic mice carrying the wild-type (CAG)15 allele of the MJD1 locus appear completely normal at 20 months. Disease severity increases with the level of expression of the expanded protein and the size of the repeat. These mice are representative of MJD and will be a valuable resource for the detailed analysis of the roles of repeat length, tissue specificity and level of expression in the neurodegenerative processes underlying MJD pathogenesis.
引用
收藏
页码:1075 / 1094
页数:20
相关论文
共 74 条
  • [1] CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease
    Abe, Y
    Tanaka, F
    Matsumoto, M
    Doyu, M
    Hirayama, M
    Kachi, T
    Sobue, G
    [J]. NEUROLOGY, 1998, 51 (03) : 882 - 884
  • [2] Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice
    Abel, A
    Walcott, J
    Woods, J
    Duda, J
    Merry, DE
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (02) : 107 - 116
  • [3] [Anonymous], 1994, MANIPULATING MOUSE E
  • [4] Dentatorubral and pallidoluysian atrophy (DRPLA) - Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
    Becher, MW
    Rubinsztein, DC
    Leggo, J
    Wagster, MV
    Stine, OC
    Ranen, NG
    Franz, ML
    Abbott, MH
    Sherr, M
    MacMillan, JC
    Barron, L
    Porteous, M
    Harper, PS
    Ross, CA
    [J]. MOVEMENT DISORDERS, 1997, 12 (04) : 519 - 530
  • [5] Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
    Becher, MW
    Kotzuk, JA
    Sharp, AH
    Davies, SW
    Bates, GP
    Price, DL
    Ross, CA
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 4 (06) : 387 - 397
  • [6] BECHER MW, 1998, MOVEMENT DISORD, V4, P519
  • [7] SCA1 TRANSGENIC MICE - A MODEL FOR NEURODEGENERATION CAUSED BY AN EXPANDED CAG TRINUCLEOTIDE REPEAT
    BURRIGHT, EN
    CLARK, HB
    SERVADIO, A
    MATILLA, T
    FEDDERSEN, RM
    YUNIS, WS
    DUVICK, LA
    ZOGHBI, HY
    ORR, HT
    [J]. CELL, 1995, 82 (06) : 937 - 948
  • [8] Carleton H. M., 1980, Carleton's histological technique
  • [9] Insertion of expanded CAG trinucleotide repeat motifs into a yeast artificial chromosome containing the human Machado-Joseph disease gene
    Cemal, CK
    Huxley, C
    Chamberlain, S
    [J]. GENE, 1999, 236 (01) : 53 - 61
  • [10] Clark HB, 1997, J NEUROSCI, V17, P7385